Worth reading
80Important
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
53.4
Year-on-year increase in operating income (¥ million)Wording
Conditional
How definitive the wording is.Contents of this document
Presentation materials for financial resultsFirst quarter of the fiscal year ending May 202713 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥428 million-1.7%
Operating profit¥106 million+100.7%
Ordinary income¥106 million+30.6%
Net income¥75 million+33.4%
Gross Profit Margin64.1 %
Operating profit margin24.9 %
Selling, general and administrative expenses
SG&A-to-sales ratioUp 2.8 percentage points year on year
Results for the three months of the current quarterCumulative first-quarter results were revenue of ¥428 million, gross profit of ¥274 million, operating profit of ¥106 million, ordinary profit of ¥106 million and net income of ¥75 million. Separate figures for the three months of the quarter and the cumulative period were Not disclosed.
Full-year earnings forecast
Net Sales
¥2,023 million
Gross profit
¥1,082 million
Operating profit
¥362 million
Ordinary income
¥362 million
Net income for the current fiscal year
¥247 million
Progress against full-year forecast 通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales21.2
Gross profit25.4
Operating profit29.4
Ordinary income29.6
Net income for the current fiscal year30.6
By service
F&I net sales20.7
C&Br net sales23.6
HR&OS net sales19.4
F&I gross profit21.2
C&Br gross profit49.9
HR&OS gross profit16.2
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
Progressed steadily, particularly in terms of profitBreakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
Year-on-year change in operating income
First-quarter operating profit for the fiscal year ending May 202653.1
F&I services-9.1
C&Br services66.4
HR&OS services3.3
Recruitment advertising costs5.5
Personnel Expenses-11.5
Other-1.1
First-quarter operating profit for the fiscal year ending May 2027106.5
Increase in gross profit62.7
Increase in SG&A expenses9.3
Assumptions Underlying the Business OutlookThe assumptions used by the company in preparing its forecast.
The company plans to increase the balance of investment assets from ¥9,521 million at the beginning of the fiscal year to ¥13,220 million at the end of the fiscal year. It plans to increase headcount by 14, mainly in the sales division and Japanese and foreign personnel placement businesses. In response to higher funding costs resulting from rising interest rates, the company is successively reviewing rates with customers.New initiatives
- Acquired a ¥1,061 million interest in business land regularly leased by a customer medical corporation
- Strengthen M&A support and fundraising support consulting
- Expand specified skilled foreign worker employment support as a growth area
- Successively review rates with customers
- Introduced a shareholder benefit program with 30 November 2026 as the first record date
Key KPIsA metric the company considers important as a management benchmark.
- Number of customers172 companies+18.6%
- Number of companies whose receivables were purchased101 companies+21.7%
- Investment asset balance¥10,603 million+22.7%
- Equity ratio20.2 %-1.1%
- Operating margin24.9 %+12.7%
Segment results
F&I
Net Sales
¥200 million+4.5%
Gross profit
¥126 million-6.7%
C&Br
Net Sales
¥130 million-10.6%
Gross profit
¥102 million+182.2%
HR&OS
Net Sales
¥97 million-0.4%
Gross profit
¥45 million+13.7%
Medium-term management plan targets
Consolidated net sales for the fiscal year ending May 20282,023
Consolidated operating profit for the fiscal year ending May 2028568
Consolidated operating profit for the fiscal year ending May 2029784
Number of foreign resident support personnel at the end of May 2029700
Financial targets
The forecast equity ratio at the end of the fiscal year ending May 2027 is 19.1%. Targets for ROE, ROIC and the D/E ratio were Not disclosed.Market Size / Share
Amount of medical and long-term care receivables assignedApproximately ¥490 billion
TAMApproximately ¥59.9 trillion
SAMApproximately ¥41.2 trillion
Balance of purchased receivables at the end of August 2026Approximately ¥8.7 billion
Number of stores and locations
The Osaka Office and Tokyo Office are listed. The number of openings and closures during the period was Not disclosed.Number of employees
The group had 94 employees as of the date of submission of this document. The company plans to increase headcount by 14 for the full fiscal year.Annual Dividend
For the fiscal year ending May 2027, the company plans to pay a year-end dividend of ¥20.00 per share. The interim dividend was Not disclosed.Payout ratio
The company states that it aims for the market's average payout ratio. A specific numerical target was Not disclosed.| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | First quarter of the fiscal year ending May 2027 |
| Net Sales | ¥428 million (YoY -1.7%) |
| Operating profit | ¥106 million (YoY +100.7%) |
| Ordinary income | ¥106 million (YoY +30.6%) |
| Net income | ¥75 million (YoY +33.4%) |
| Gross Profit Margin | 64.1 % |
| Operating profit margin | 24.9 % |
| Selling, general and administrative expenses | value Not disclosed / SG&A-to-sales ratio Up 2.8 percentage points year on year |
| Results for the three months of the current quarter | Cumulative first-quarter results were revenue of ¥428 million, gross profit of ¥274 million, operating profit of ¥106 million, ordinary profit of ¥106 million and net income of ¥75 million. Separate figures for the three months of the quarter and the cumulative period were Not disclosed. |
| Full-year earnings forecast | Net Sales ¥2,023 million / Gross profit ¥1,082 million / Operating profit ¥362 million / Ordinary income ¥362 million / Net income for the current fiscal year ¥247 million |
| Progress against full-year forecast | Net Sales 21.2 / Gross profit 25.4 / Operating profit 29.4 / Ordinary income 29.6 / Net income for the current fiscal year 30.6 / By service F&I net sales 20.7 / C&Br net sales 23.6 / HR&OS net sales 19.4 / F&I gross profit 21.2 / C&Br gross profit 49.9 / HR&OS gross profit 16.2 |
| Self-assessment against the plan | Progressed steadily, particularly in terms of profit |
| Segment results | F&I Net Sales ¥200 million (YoY +4.5%) / Gross profit ¥126 million (YoY -6.7%) / C&Br Net Sales ¥130 million (YoY -10.6%) / Gross profit ¥102 million (YoY +182.2%) / HR&OS Net Sales ¥97 million (YoY -0.4%) / Gross profit ¥45 million (YoY +13.7%) |
| Breakdown of Factors Affecting the Change | Year-on-year change in operating income First-quarter operating profit for the fiscal year ending May 2026 53.1 / F&I services -9.1 / C&Br services 66.4 / HR&OS services 3.3 / Recruitment advertising costs 5.5 / Personnel Expenses -11.5 / Other -1.1 / First-quarter operating profit for the fiscal year ending May 2027 106.5 / Increase in gross profit 62.7 / Increase in SG&A expenses 9.3 |
| Key KPIs | Number of customers 172 companies (YoY +18.6%), Number of companies whose receivables were purchased 101 companies (YoY +21.7%), Investment asset balance ¥10,603 million (YoY +22.7%), Equity ratio 20.2 % (YoY -1.1%), Operating margin 24.9 % (YoY +12.7%) |
| Number of stores and locations | The Osaka Office and Tokyo Office are listed. The number of openings and closures during the period was Not disclosed. |
| Number of employees | The group had 94 employees as of the date of submission of this document. The company plans to increase headcount by 14 for the full fiscal year. |
| Assumptions Underlying the Business Outlook | The company plans to increase the balance of investment assets from ¥9,521 million at the beginning of the fiscal year to ¥13,220 million at the end of the fiscal year. It plans to increase headcount by 14, mainly in the sales division and Japanese and foreign personnel placement businesses. In response to higher funding costs resulting from rising interest rates, the company is successively reviewing rates with customers. |
| Medium-term management plan targets | Consolidated net sales for the fiscal year ending May 2028 2,023 / Consolidated operating profit for the fiscal year ending May 2028 568 / Consolidated net sales for the fiscal year ending May 2029 Not disclosed / Consolidated operating profit for the fiscal year ending May 2029 784 / Number of foreign resident support personnel at the end of May 2029 700 / Investment asset balance at the end of the fiscal year ending May 2029 Not disclosed |
| Financial targets | The forecast equity ratio at the end of the fiscal year ending May 2027 is 19.1%. Targets for ROE, ROIC and the D/E ratio were Not disclosed. |
| Annual Dividend | For the fiscal year ending May 2027, the company plans to pay a year-end dividend of ¥20.00 per share. The interim dividend was Not disclosed. |
| Payout ratio | The company states that it aims for the market's average payout ratio. A specific numerical target was Not disclosed. |
| Market Size / Share | Amount of medical and long-term care receivables assigned Approximately ¥490 billion / TAM Approximately ¥59.9 trillion / SAM Approximately ¥41.2 trillion / Balance of purchased receivables at the end of August 2026 Approximately ¥8.7 billion |
| New initiatives | Acquired a ¥1,061 million interest in business land regularly leased by a customer medical corporation, Strengthen M&A support and fundraising support consulting, Expand specified skilled foreign worker employment support as a growth area, Successively review rates with customers, Introduced a shareholder benefit program with 30 November 2026 as the first record date |
Items this document does not state (6)
Unit price and quantity metricsRisk amount incorporated into the outlookAcquisition of treasury sharesCapital expendituresOrders received and order backlogKey points of the Q&A
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue from M&A support and fundraising support consulting grew substantially, increasing gross profit. SG&A expenses, including personnel costs, also increased, but the increase in gross profit covered these costs. At C&Br, high-margin consulting revenue increased, while at F&I, gross profit decreased due to the reaction from the relatively high level of fee income in the same quarter of the previous year from new and increased contracts with high profit margins.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.